Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis

BACKGROUND AND OBJECTIVE: As new migraine prevention treatments are developed, the onset of a preventive effect, how long it is maintained and whether patients initially non-responsive develop clinically meaningful responses with continued treatment can be assessed. METHODS: Analyses were conducted...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurol Neurosurg Psychiatry
Egile Nagusiak: Goadsby, Peter J, Dodick, David W, Martinez, James M, Ferguson, Margaret B, Oakes, Tina M, Zhang, Qi, Skljarevski, Vladimir, Aurora, Sheena K
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2019
Gaiak:
Migraine
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6691875/
https://ncbi.nlm.nih.gov/pubmed/31004075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2018-320242
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak